Kowalski Lab

The Kowalski – Muegge Lab has been featured on the Dell Medical School Website! The blog post highlights our most recent event, The Sprint for Cancer Genomics, and can be read HERE!

The blog is titled “Learning by ‘Sprinting’: UT Undergraduates Tackle Cancer Genomics in an Immersive Event” and was authored by Jeanne Kowalski-Muegge, Ph.D., professor of oncology at Dell Med, Ginger M. Okoro, MPA, manager of department operations in the Livestrong Cancer Institutes, and Anish Singh, an undergraduate student at The University of Texas at Austin.

A Special Episode that informs about the Cancer Genomics Sprint hosted by Kowalski-Muegge Lab

This special episode highlights the first-ever science SPRINT for Cancer Genomics on the Dell Medical School campus. The purpose of this ‘sprint’ is to educate undergraduates on molecular-targeted therapies for treatment of cancer by challenging them in 6 hours to define a treatment trajectory for a case using molecular profiling results and what they will learn in real-time about the disease, biomarkers, and public resources.

This incredible opportunity is presented by Dr. Jeanne Kowalski-Muegge and her team that comprises the Kowalski-Muegge Lab in the Livestrong Cancer Institutes. Jeanne is a Professor of Oncology, the Associate Director of Cancer Clinical Genomics, and Co-Program Leader of Quantitative Oncology at Dell Medical School.

A Livestrong Cancer Institutes Podcast Discussion with Professor Kowalski-Muegge

Professor Kowalski-Muegge was invited to talk about her development and lead of the Livestrong Cancer Institute’s first-ever research molecular tumor board, TOMWAY (Total Molecular Profiles with Actionable Yields). In her leadership role as Associate Director, Cancer Clinical Genomics, Dr. Kowalski-Muegge is leading efforts to educate and inform on molecularly-targeted treatment for cancer.